WeLeader Biomedical Co., Ltd. (7713)
TWSE
Closed
Aug 25, 2026
Day's Range
72.9052 wk Range
66.00Overview - 7713 - WeLeader Biomedical Co., Ltd.
Key Statistics
Valuation
Enterprise Value
4.17B
P/E (Trailing)
‪14.42‬
PEG Ratio
‪0.62‬
Price / Sales (TTM)
‪2.74‬
Price / Book
‪2.76‬
EV / EBITDA
‪12.13‬
Profitability
Gross Margin
‪34.51%‬
Profit Margin
‪20.61%‬
Operating Margin
‪26.95%‬
Return on Assets
‪8.34%‬
Return on Equity
‪21.80%‬
Ownership
Shares Outstanding
45.47M
Float
8.14M
Held by Insiders
‪84.35%‬
Held by Institutions
‪0.00%‬
Price stats
Beta
‪0.05‬
50-Day Avg
‪70.63‬
200-Day Avg
‪70.82‬
Dividends
Payout Ratio
‪81.03%‬
Frequency
Annual
Market Cap - 7713 - WeLeader Biomedical Co., Ltd.
Peers - 7713 - WeLeader Biomedical Co., Ltd.
Peer Comparison
Compared with companies in Medical Devices listed on TWSE.
Profile Summary - 7713 - WeLeader Biomedical Co., Ltd.
About
WeLeader Biomedical Co., Ltd. is a Taiwan-based healthcare company specializing in the distribution and agency of in vitro diagnostic products, medical diagnostic equipment, and reagent-related services. Founded in 1992 and headquartered in Kaohsiung, the company provides a broad portfolio, including serum…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
